Teva Pharmaceutical Indus Market Sentiment

Teva Pharmaceutical Industries Ltd

TEVANYSE

Trade with Public

$39.19

-1.03-2.56%

가까이에: Sep 25, 5:00 PM EST

$39.19

N/A

시간외: Sep 25, 4:35 PM EST

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Teva Pharmaceutical Indus Market Sentiment

Market sentiment signals for Teva Pharmaceutical Indus (TEVA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.7% short float

Options Flow▲ 0.32 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

14 analysts

Options Flow (P/C)

0.32

More calls — Bullish

1,009 calls · 325 puts

Avg Consensus PT

$38

-3.2%

Highest Price Target

$50

+27.6%

Oppenheimer

Lowest Price Target

$11

-71.9%

Goldman Sachs

Short Interest

2.7%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 23, 2026	Oppenheimer	Les Sulewski—	+27.6%	$50	Initiate	Outperform
Sep 9, 2026	Leerink Partners	Daniel Clark—	+14.8%	$45	Initiate	Outperform
Sep 4, 2026	UBS	Ashwani Verma—	+22.5%	$42 → $48	Maintained	Buy
Aug 12, 2026	Barclays	Glen Santangelo—	+7.2%	$40 → $42	Maintained	Overweight
Jul 28, 2026	Piper Sandler	David Amsellem—	+12.3%	$42 → $44	Maintained	Overweight
May 6, 2026	Barclays	Glen Santangelo—	+2.1%	$38 → $40	Maintained	Overweight
Apr 30, 2026	JP Morgan	Chris Schott—	+2.1%	$35 → $40	Maintained	Overweight
Apr 30, 2026	UBS	Ashwani Verma—	+7.2%	$36 → $42	Maintained	Buy
Apr 30, 2026	Piper Sandler	David Amsellem—	+7.2%	$41 → $42	Maintained	Overweight
Apr 30, 2026	Truist Securities	Les Sulewski—	+14.8%	$42 → $45	Maintained	Buy
Apr 9, 2026	B of A Securities	Jason Gerberry—	+7.2%	$38 → $42	Maintained	Buy
Mar 4, 2026	Piper Sandler	David Amsellem—	+4.6%	$40 → $41	Maintained	Overweight
Feb 18, 2026	Truist Securities	Les Sulewski—	+7.2%	$38 → $42	Maintained	Buy
Feb 9, 2026	Goldman Sachs	Matt Dellatorre—	+14.8%	$36 → $45	Maintained	Buy
Jan 30, 2026	Barclays	Glen Santangelo—	-3.0%	$35 → $38	Maintained	Overweight
Jan 29, 2026	Scotiabank	Louise Chen—	+2.1%	$35 → $40	Maintained	Sector Outperform
Jan 29, 2026	Truist Securities	Les Sulewski—	-3.0%	$36 → $38	Maintained	Buy
Jan 6, 2026	Jefferies	Glen Santangelo—	+2.1%	$29 → $40	Maintained	Buy
Dec 22, 2025	Piper Sandler	David Amsellem—	+2.1%	$30 → $40	Maintained	Overweight
Dec 19, 2025	Goldman Sachs	Matt Dellatorre—	-10.7%	$31 → $35	Maintained	Buy
Dec 16, 2025	JP Morgan	Chris Schott—	-10.7%	$28 → $35	Maintained	Overweight
Dec 9, 2025	B of A Securities	Jason Gerberry—	-18.3%	$29 → $32	Maintained	Buy
Dec 9, 2025	Barclays	Glen Santangelo—	-10.7%	$35	Initiate	Overweight
Dec 8, 2025	Goldman Sachs	Matt Dellatorre—	-20.9%	$28 → $31	Maintained	Buy
Dec 5, 2025	Scotiabank	Louise Chen—	-10.7%	$35	Initiate	Sector Outperform